Inclusion of PF68 surfactant improves stability of rAAV titer when passed through a surgical device used in retinal gene therapy

Inclusion of PF68 surfactant improves stability of rAAV titer when passed through a surgical device used in retinal gene therapy

Recent advances in recombinant adeno-associated virus (rAAV) gene therapy for choroideremia show gene replacement to be a promising approach. It is, however, well known that contact of vector solution with plastic materials in the surgical device may result in non-specific adsorption with resulting...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Patrício, M, Cox, C, Blue, C, Barnard, A, Martinez-Fernandez De La Camara, C, Maclaren, R
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	Cell Press 2019

Míreanna comhchosúla

Inclusion of PF68 Surfactant Improves Stability of rAAV Titer when Passed through a Surgical Device Used in Retinal Gene Therapy
de réir: Maria I. Patrício, et al.
Foilsithe / Cruthaithe: (2020-06-01)

Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
de réir: Hironori Okada, et al.
Foilsithe / Cruthaithe: (2013-01-01)

An amplification-free CRISPR-Cas12a assay for titer determination and composition analysis of the rAAV genome
de réir: Lei Yu, et al.
Foilsithe / Cruthaithe: (2024-09-01)

The biological activity of AAV vectors for choroideremia gene therapy can be measured by in vitro prenylation of RAB6A
de réir: Patrício, M, et al.
Foilsithe / Cruthaithe: (2018)

rAAV-mediated subcellular targeting of optogenetic tools in retinal ganglion cells in vivo.
de réir: Chaowen Wu, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Crucial aspects for maintaining rAAV stability
de réir: Johannes Lengler, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Polyfunctional T cells and unique cytokine clusters imprint the anti rAAV2/rAAV9 vector immune response
de réir: Stephan J. Holtkamp, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Differential effects of two MRI contrast agents on the integrity and distribution of rAAV2 and rAAV5 in the rat striatum
de réir: Sue Osting, et al.
Foilsithe / Cruthaithe: (2014-01-01)

rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates
de réir: Akiko Ishii, et al.
Foilsithe / Cruthaithe: (2020-09-01)

CRISPR screen reveals modifiers of rAAV production including known rAAV infection genes playing an unexpected role in vector production
de réir: Emily E. O’Driscoll, et al.
Foilsithe / Cruthaithe: (2025-03-01)

Subcellular distribution of the rAAV genome depends on genome structure
de réir: Nuri Oh, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Performance of Cardiotropic rAAV Vectors Is Dependent on Production Method
de réir: Renuka Rao, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Monobac System–A Single Baculovirus for the Production of rAAV
de réir: Lionel Galibert, et al.
Foilsithe / Cruthaithe: (2021-08-01)

Immunomodulation in Administration of rAAV: Preclinical and Clinical Adjuvant Pharmacotherapies
de réir: Wing Sum Chu, et al.
Foilsithe / Cruthaithe: (2021-04-01)

rAAV1-EGFP和rAAV2-EGFP转染犬骨髓间充质干细胞的比较
Foilsithe / Cruthaithe: (2009-01-01)

rAAV Manufacturing: The Challenges of Soft Sensing during Upstream Processing
de réir: Cristovão Freitas Iglesias, et al.
Foilsithe / Cruthaithe: (2023-02-01)

Optimization of miR-22 expression cassette for rAAV delivery on diabetes
de réir: Li Yang, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Partial genome content within rAAVs impacts performance in a cell assay-dependent manner
de réir: Bryan Troxell, et al.
Foilsithe / Cruthaithe: (2023-09-01)

The Biological Activity of AAV Vectors for Choroideremia Gene Therapy Can Be Measured by In Vitro Prenylation of RAB6A
de réir: Maria I. Patrício, et al.
Foilsithe / Cruthaithe: (2018-06-01)

Unlocking DOE potential by selecting the most appropriate design for rAAV optimization
de réir: Konstantina Tzimou, et al.
Foilsithe / Cruthaithe: (2024-12-01)

An efficient rAAV vector for protein expression in cortical parvalbumin expressing interneurons
de réir: Tatiana Tkatch, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Proteomics analysis of co-purifying cellular proteins associated with rAAV vectors.
de réir: Biao Dong, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Effects of Thermally Induced Configuration Changes on rAAV Genome’s Enzymatic Accessibility
de réir: Yinxia Xu, et al.
Foilsithe / Cruthaithe: (2020-09-01)

The AAV capsid can influence the epigenetic marking of rAAV delivered episomal genomes in a species dependent manner
de réir: Adriana Gonzalez-Sandoval, et al.
Foilsithe / Cruthaithe: (2023-04-01)

Efficient construction of rAAV-based gene targeting vectors by Golden Gate cloning
de réir: Yonglun Luo, et al.
Foilsithe / Cruthaithe: (2014-05-01)

rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis
de réir: Weiran Shen, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Prostaglandin-based rAAV-mediated glaucoma gene therapy in Brown Norway rats
de réir: Kristina J. Chern, et al.
Foilsithe / Cruthaithe: (2022-11-01)

rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis
de réir: Artem A. Derkaev, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Gene delivery to adipose tissue using transcriptionally targeted rAAV8 vectors.
de réir: Silke Uhrig-Schmidt, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Inclusion of the woodchuck hepatitis virus posttranscriptional regulatory element enhances AAV2-driven transduction of mouse and human retina
de réir: Patrício, M, et al.
Foilsithe / Cruthaithe: (2017)

The combination of rAAV pseudo-lipid nanoparticle and triamcinolone acetonide enables multi-administration to liver
de réir: Chunmei Gan, et al.
Foilsithe / Cruthaithe: (2025-03-01)

An AAV-Based NF-κB-Targeting Gene Therapy (rAAV-DMP-miR533) to Inflammatory Diseases
de réir: Luo T, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Choroideremia: molecular mechanisms and development of AAV gene therapy
de réir: Patrício, M, et al.
Foilsithe / Cruthaithe: (2018)

Impact of vital dyes on cell viability and transduction efficiency of AAV vectors used in retinal gene therapy surgery: an in vitro and in vivo analysis
de réir: Salvetti, A, et al.
Foilsithe / Cruthaithe: (2017)

Development of recombinant Adeno-Associated Viral vector (rAAV) for passive immunisation against ebola
de réir: Tan, T, et al.
Foilsithe / Cruthaithe: (2017)

Intramuscular rAAV2/8 mediated expression of etanercept in mice with collagen-induced arthritis
de réir: Habib, O, et al.
Foilsithe / Cruthaithe: (2019)

Identification of the role of SNARE proteins in rAAV vector production through interaction with the viral MAAP
de réir: Cagla Aksu Kuz, et al.
Foilsithe / Cruthaithe: (2025-03-01)

Temporal insights into molecular and cellular responses during rAAV production in HEK293T cells
de réir: Alok Tanala Patra, et al.
Foilsithe / Cruthaithe: (2024-09-01)

PEG-mediated transduction of rAAV as a platform for spatially confined and efficient gene delivery
de réir: Liang Zou, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Characterization of Recombinant Adeno-Associated Viruses (rAAVs) for Gene Therapy Using Orthogonal Techniques
de réir: Liam Cole, et al.
Foilsithe / Cruthaithe: (2021-04-01)